Insider Trades for PAREXEL International Corporation show that the latest trade was made on 8 May 2017 where Harford Simon N R, the Chief Financial Officer completed a transaction type "Buy" in which 10736 shares were traded at a price of $0. Its price to sales ratio of 1.83 ranks lower than the industry's 109.55.
Several research analysts recently issued reports on PRXL shares. Avondale maintained PAREXEL International Corporation (NASDAQ:PRXL) on Monday, April 11 with "Underperform" rating. Mizuho began coverage on shares of PAREXEL International Corporation in a report on Thursday, March 23rd. They set a "neutral" rating and a $86.00 price objective for the company. $66.88's average target is -23.35% below currents $87.25 stock price. Credit Suisse Group reissued a "neutral" rating and issued a $83.00 price objective (up from $65.00) on shares of PAREXEL International Corporation in a research report on Tuesday, June 6th.
05/23/2017 - PAREXEL International Corporation was upgraded to "neutral" by analysts at Goldman Sachs. 436,213 shares of the company were exchanged. Analysts have a mean recommendation of 2.90 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). The stock has a consensus rating of "Hold" and a consensus price target of $72.83.
The share price of the company (NASDAQ:PRXL) was up +0.24%, with a high of 0.00 during the day and the volume of PAREXEL International Corporation shares traded was 0. The Papp L Roy & Associates holds 32,501 shares with $2.14 million value, down from 48,016 last quarter. The company has a 50 day moving average of $78.71 and a 200 day moving average of $68.58. Based on a recent trade, the shares are -0.23% away from the 52-week high and 70.54% from the 52-week low. The Firm processes and sells commodity yarns, specialized yarns and premier value-added yarns. Comparatively, PAREXEL International Corporation posted earnings of $1.11 per share in the same quarter past year. While in the same Quarter Previous year, the Actual EPS was $0.94. PAREXEL International Corporation had a net margin of 5.12% and a return on equity of 28.68%. The firm had revenue of $529.30 million for the quarter, compared to analyst estimates of $529.38 million. During the same period past year, the company posted $0.89 EPS. On average, equities research analysts forecast that PAREXEL International Corporation will post $3.24 earnings per share for the current fiscal year.
Trump says he is 'very supportive' of Senate healthcare bill
Discrimination based on pre-existing conditions could become the norm again. "Millions of families will lose coverage entirely". Dean Heller of Nevada is up for reelection next year. "If this bill isn't good for Kansas, it isn't good for me", Moran added.
Stock has got outperform rating from 2 of Thomson Reuters analysts whereas 0 given HOLD rating to the stock. If you are reading this report on another site, it was stolen and reposted in violation of USA & worldwide copyright law. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2017/06/22/parexel-internationals-prxl-neutral-rating-reaffirmed-at-credit-suisse-group-ag-updated-updated.html.
Stock of Alere Inc. Cryder Capital Partners LLP raised its stake in PAREXEL International Corporation by 21.0% in the third quarter. BlackRock Inc. now owns 5,513,456 shares of the medical research company's stock worth $347,955,000 after buying an additional 5,489,460 shares during the period.
Let's have a look at some of the important valuation ratios of the PAREXEL International Corporation (PRXL). Clearbridge Investments LLC now owns 1,118,312 shares of the medical research company's stock valued at $70,577,000 after buying an additional 99,758 shares in the last quarter. Canada Pension Plan Investment Board purchased a new stake in shares of PAREXEL International Corporation during the first quarter valued at approximately $26,891,000. Nomura Holdings Inc. now owns 1,381,087 shares of the medical research company's stock valued at $87,088,000 after buying an additional 904,236 shares in the last quarter. Congress Asset Management Co. Wesbanco National Bank has 0.04% invested in PAREXEL International Corporation (NASDAQ:PRXL) for 9,525 shares. The Company's divisions include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The Firm provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology services and products to pharmaceutical, biotechnology and medical device industries.
Comments